-
IBO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
Impact BioMedical (IBO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.67 mm | 2.67 mm | 2.67 mm | 2.67 mm | 2.67 mm | 2.67 mm |
Cash burn (monthly) | (no burn) | (no burn) | (no burn) | (no burn) | 428.33 k | 258.00 k |
Cash used (since last report) | n/a | n/a | n/a | n/a | 2.13 mm | 1.28 mm |
Cash remaining | n/a | n/a | n/a | n/a | 537.53 k | 1.38 mm |
Runway (months of cash) | n/a | n/a | n/a | n/a | 1.3 | 5.4 |
13F holders | Current |
---|---|
Total holders | 8 |
Opened positions | 8 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 32.12 mm |
Total shares | 29.67 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Jane Street | 13.36 k | $26.72 mm |
HRT Financial | 12.50 k | $25.00 k |
BAC Bank of America | 2.60 k | $5.19 mm |
BCS Barclays | 1.12 k | $2.00 k |
MS Morgan Stanley | 58.00 | $116.00 k |
WFC Wells Fargo & Company | 29.00 | $58.00 k |
UBS UBS | 3.00 | $6.00 k |
Group One Trading | 1.00 | $2.00 k |
Proequities | 0.00 | $0.00 |